Creative Medical CELZ Stock
Creative Medical Price Chart
Creative Medical CELZ Financial and Trading Overview
| Creative Medical stock price | 0.89 USD |
| Previous Close | 0.92 USD |
| Open | 0.9 USD |
| Bid | 0.65 USD x 200 |
| Ask | 1.2 USD x 200 |
| Day's Range | 0.89 - 0.92 USD |
| 52 Week Range | 0.62 - 6.25 USD |
| Volume | 43.68K USD |
| Avg. Volume | 6.79M USD |
| Market Cap | 6.82M USD |
| Beta (5Y Monthly) | 1.905 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.07 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 USD |
CELZ Valuation Measures
| Enterprise Value | -2735682 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.0204545 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2272.7053 |
| Price/Book (mrq) | 0.67366844 |
| Enterprise Value/Revenue | -911.894 |
| Enterprise Value/EBITDA | 0.447 |
Trading Information
Creative Medical Stock Price History
| Beta (5Y Monthly) | 1.905 |
| 52-Week Change | -73.020% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 6.25 USD |
| 52 Week Low | 0.62 USD |
| 50-Day Moving Average | 1.01 USD |
| 200-Day Moving Average | 1.7 USD |
CELZ Share Statistics
| Avg. Volume (3 month) | 6.79M USD |
| Avg. Daily Volume (10-Days) | 357.75K USD |
| Shares Outstanding | 7.59M |
| Float | 6.56M |
| Short Ratio | 0.11 |
| % Held by Insiders | 15.70% |
| % Held by Institutions | 5.65% |
| Shares Short | 84.26K |
| Short % of Float | 1.28% |
| Short % of Shares Outstanding | 1.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -208004.39% |
| Gross Margin | 66.86% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -47.32% |
| Return on Equity (ttm) | -77.88% |
Income Statement
| Revenue (ttm) | 3K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 2.01K USD |
| EBITDA | -6126351 USD |
| Net Income Avi to Common (ttm) | -6040661 USD |
| Diluted EPS (ttm) | -2.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.84M USD |
| Total Cash Per Share (mrq) | 1.34 USD |
| Total Debt (mrq) | 14.19K USD |
| Total Debt/Equity (mrq) | 0.16 USD |
| Current Ratio (mrq) | 12.91 |
| Book Value Per Share (mrq) | 1.333 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5901718 USD |
| Levered Free Cash Flow (ttm) | -3456562 USD |
Profile of Creative Medical
| Country | United States |
| State | AZ |
| City | Phoenix |
| Address | 211 East Osborn Road |
| ZIP | 85012 |
| Phone | 480 399 2822 |
| Website | https://www.creativemedicaltechnology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Q&A For Creative Medical Stock
What is a current CELZ stock price?
Creative Medical CELZ stock price today per share is 0.89 USD.
How to purchase Creative Medical stock?
You can buy CELZ shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Creative Medical?
The stock symbol or ticker of Creative Medical is CELZ.
Which industry does the Creative Medical company belong to?
The Creative Medical industry is Biotechnology.
How many shares does Creative Medical have in circulation?
The max supply of Creative Medical shares is 7.59M.
What is Creative Medical Price to Earnings Ratio (PE Ratio)?
Creative Medical PE Ratio is now.
What was Creative Medical earnings per share over the trailing 12 months (TTM)?
Creative Medical EPS is -2.07 USD over the trailing 12 months.
Which sector does the Creative Medical company belong to?
The Creative Medical sector is Healthcare.
Creative Medical CELZ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27538.69 USD — |
-0.22
|
6.46B USD — | 27341.31 USD — | 27547.2 USD — | — - | 6.46B USD — |
- {{ link.label }} {{link}}
